AKR1C1 and myeloid sarcoma: Our previous data did not find trends in correlations with neither indices of MS severity nor with MS presence [33], which was consistent with the results of transcriptional analysis of AKR1C isoforms in the study by Noorbakhsh et al. that also showed no significant alteration for the AKR1C1 transcripts in the white matter of patients when compared with controls [18].